Track and Trace Solutions Market Share, Size, Trends, Industry Analysis Report, By Product (Hardware, Software); By Technology; By Application; By End-Use; By Region; Segment Forecast, 2021 - 2028
Description
The global track and trace solutions market size is expected to reach USD 29.83 billion by 2034 according to a new study by Polaris Market Research. The report “Track and Trace Solutions Market Share, Size, Trends, Industry Analysis Report, By Product (Hardware, Software); By Technology; By Application; By End-Use; By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The stringent execution of serialization on medical products by many countries across the globe is mainly driving the growth of the global market across the globe. The emergence of the COVID-19 pandemic and the advantages associated with the solutions such as transparency and product ID identification are expected to contribute to the upward growth of the market during the forecast period.
Developed countries such as the U.S. have stricter regulations on the serialization of medical products. The approval of vaccines will help in the adoption of track and trace solutions. Moderna, which has developed messenger RNA (mRNA) vaccines for COVID-19, has introduced SAP Digital Supply Chain solutions for the distribution and serialization of its vaccine in December 2020.
The industry is segmented into Barcodes and RFID based on technology. Pharmaceutical industries mostly use 2D barcode technology. In contrast, Radio-frequency identification (RFID) technology is seeing significant growth in recent years as it is employed in authentication and tracing vaccines, testing kits, and others.
The product has main applications in the serialization and aggregation of medical products in pharmaceutical and medical devices companies. Most of the products are software-based and hardware-based systems and are showing steep growth due to the increasing need for printing and marking equipment in the serialization of medical products and technological advancements in Thermal Transfer Overprinting and laser marking systems.
Market participants include Mettler-Toledo International, Inc., Axway, Optel Vision, Adents International, TraceLink, Inc., Antares Vision Srl, Seidenader Maschinenbau GmbH, Systech, Inc., Siemens AG, and ACG Worldwide are some of the key players operating in the global market.
Polaris Market Research has segmented the track and trace solutions market report on the basis of product, technology, application, end-use, and region:
Track and Trace Solutions, Product Outlook (Revenue - USD Million, 2020 – 2034)
Hardware
Printing & Marking
Monitoring & Verification
Labeling
Others
Software
Plant manager software
Line controller software
Bundle tracking software
Others
Track and Trace Solutions, Technology Outlook (Revenue - USD Million, 2020 – 2034)
Barcodes
RFID
Track and Trace Solutions, Application Channel Outlook (Revenue - USD Million, 2020 – 2034)
Serialization
Bottle serialization
Label serialization
Carton serialization
Data matrix serialization
Aggregation
Case aggregation
Bundle aggregation
Pallet aggregation
Track and Trace Solutions, End-Use Outlook (Revenue - USD Million, 2016–2028)
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Healthcare
Food & Beverage
Consumer Goods
Luxury Goods
Track and Trace Solutions, Regional Outlook (Revenue - USD Million, 2020 –2034)
North America
U.S.
Canada
Europe
Germany
UK
Italy
France
Spain
Austria
Netherlands
Asia Pacific
China
Japan
India
Indonesia
Malaysia
South Korea
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Israel
Saudi Arabia
South Africa
UAE
The stringent execution of serialization on medical products by many countries across the globe is mainly driving the growth of the global market across the globe. The emergence of the COVID-19 pandemic and the advantages associated with the solutions such as transparency and product ID identification are expected to contribute to the upward growth of the market during the forecast period.
Developed countries such as the U.S. have stricter regulations on the serialization of medical products. The approval of vaccines will help in the adoption of track and trace solutions. Moderna, which has developed messenger RNA (mRNA) vaccines for COVID-19, has introduced SAP Digital Supply Chain solutions for the distribution and serialization of its vaccine in December 2020.
The industry is segmented into Barcodes and RFID based on technology. Pharmaceutical industries mostly use 2D barcode technology. In contrast, Radio-frequency identification (RFID) technology is seeing significant growth in recent years as it is employed in authentication and tracing vaccines, testing kits, and others.
The product has main applications in the serialization and aggregation of medical products in pharmaceutical and medical devices companies. Most of the products are software-based and hardware-based systems and are showing steep growth due to the increasing need for printing and marking equipment in the serialization of medical products and technological advancements in Thermal Transfer Overprinting and laser marking systems.
Market participants include Mettler-Toledo International, Inc., Axway, Optel Vision, Adents International, TraceLink, Inc., Antares Vision Srl, Seidenader Maschinenbau GmbH, Systech, Inc., Siemens AG, and ACG Worldwide are some of the key players operating in the global market.
Polaris Market Research has segmented the track and trace solutions market report on the basis of product, technology, application, end-use, and region:
Track and Trace Solutions, Product Outlook (Revenue - USD Million, 2020 – 2034)
Hardware
Printing & Marking
Monitoring & Verification
Labeling
Others
Software
Plant manager software
Line controller software
Bundle tracking software
Others
Track and Trace Solutions, Technology Outlook (Revenue - USD Million, 2020 – 2034)
Barcodes
RFID
Track and Trace Solutions, Application Channel Outlook (Revenue - USD Million, 2020 – 2034)
Serialization
Bottle serialization
Label serialization
Carton serialization
Data matrix serialization
Aggregation
Case aggregation
Bundle aggregation
Pallet aggregation
Track and Trace Solutions, End-Use Outlook (Revenue - USD Million, 2016–2028)
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Healthcare
Food & Beverage
Consumer Goods
Luxury Goods
Track and Trace Solutions, Regional Outlook (Revenue - USD Million, 2020 –2034)
North America
U.S.
Canada
Europe
Germany
UK
Italy
France
Spain
Austria
Netherlands
Asia Pacific
China
Japan
India
Indonesia
Malaysia
South Korea
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Israel
Saudi Arabia
South Africa
UAE
Table of Contents
120 Pages
- Chapter 1.Introduction
- 1.1Report Description
- 1.1.1Objective of the Study
- 1.1.2Market Scope
- 1.1.3Assumptions
- 1.2Stakeholders
- Chapter 2.Research Methodology
- 2.1Research Methodology
- 2.2Research Scope and Assumptions
- 2.3Information Procurement
- 2.3.1Purchased Database
- 2.3.2Internal Database
- 2.3.3Secondary Sources
- 2.3.4Third Party Perspective
- 2.3.5Primary Research
- 2.4Information Analysis
- 2.4.1Data Analysis Models
- 2.5Market Formulation and Data Visualization
- 2.6Data Validation and Publishing (Secondary Sources)
- Chapter 3.Executive Summary
- Chapter 4.Market Insights
- 4.1Germany Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market – Industry snapshot
- 4.2Germany Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market - Value Chain Analysis
- 4.3Germany Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Dynamics
- 4.3.1Drivers and Opportunities
- 4.3.1.1Rising Healthcare Spending
- 4.3.1.2Ongoing Clinical Trials and Research Collaborations
- 4.4Germany Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market – Porter’s Five Forces
- 4.4.1Threat of Substitutes: (Low)
- 4.4.2Threat of New Entrants: (Low)
- 4.4.3Bargaining Power of Buyers: (High)
- 4.4.4Bargaining Power of Suppliers: (Moderate)
- 4.4.5Competitive Rivalry: (Moderate)
- 4.5Germany Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market – PESTLE Analysis
- 4.6BPDCN Patient Analysis in Germany
- 4.6.1BPDCN Patient Numbers in Germany (2021-2034)
- 4.6.2Detailed Age-Specific Incidence Estimates
- 4.6.3Factors Contributing to Apparent Increase in BPDCN Cases
- 4.6.3.1Improved Diagnostic Recognition and Classification
- 4.6.3.2Enhanced Disease Awareness Among Clinicians
- 4.6.3.3Aging Population and Demographic Shifts
- 4.6.3.4Expanded Genetic and Molecular Testing
- 4.7Therapy and Diagnostics Drivers in the Germany BPDCN Market
- 4.7.1Upcoming Advances in Diagnostics
- 4.7.2Significance of New Generation Sequencing
- 4.7.3Diagnostics for CD123 Development Analysis
- 4.8Trends in Targeted Therapies
- 4.8.1Upcoming Targeted Therapies/Immunotherapy
- 4.8.2Evolution of Therapy Beyond 2025
- 4.9Role of Individual Physician Groups in Shaping the BPDCN Market Landscape Analysis
- 4.10Patient Journey in the BPDCN Treatment Landscape Analysis
- 4.11Challenges/Restraint Analysis for German BPDCN Market
- 4.11.1High Treatment Cost
- 4.11.2Regulatory and Market Access Barriers
- 4.12Analyst View Point/Suggestion/Plan of Action for Market Hurdles
- 4.12.1Addressing High Treatment Costs
- 4.12.2Overcoming Regulatory and Market Access Barriers
- 4.12.3Stakeholder Collaboration and Advocacy
- Chapter 5.Germany Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Assessment, By Type
- 5.1Introduction
- 5.2Therapy
- 5.2.1Chemotherapy
- 5.2.2Immunotherapy
- 5.2.3Stem Cell Transplantation
- 5.3Diagnostic
- 5.3.1Flow Cytometry
- 5.3.2Molecular Testing
- 5.3.3Histopathology
- 5.3.4Imaging Techniques
- Chapter 6.Germany Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Assessment, By End User
- 6.1Introduction
- 6.2Hospitals
- 6.3Specialty Clinics
- 6.4Diagnostic Laboratories
- 6.5Others
- Chapter 7.Competitive Landscape
- 7.1BPDCN Company Analysis in Germany
- 7.1.1Key Therapeutic Companies in Germany
- 7.1.2Key Diagnostic Companies in Germany
- 7.2Key Market Players: Categorization
- 7.3Vendor Landscape
- Chapter 8.Company Profiles
- 8.1Jazz pharmaceuticals
- 8.1.1Business Overview
- 8.1.2Financial Snapshot
- 8.1.3Products Benchmarking
- 8.2AbbVie
- 8.2.1Business Overview
- 8.2.2Financial Snapshot
- 8.2.2.1Revenue by Region
- 8.2.3Products Benchmarking
- 8.3The Menarini Group
- 8.3.1Business Overview
- 8.3.2Products Benchmarking
- 8.3.3Recent Development
- 8.4NIPPON SHINYAKU CO., LTD.
- 8.4.1Business Overview
- 8.4.2Financial Snapshot
- 8.4.3Products Benchmarking
- 8.4.4Recent Developments
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
